市場調查報告書
商品編碼
1410776
腦積水流器市場規模:按細分市場、份額、監管、報銷、程序、預測至 2033 年Hydrocephalus Shunts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
使用腦脊髓液 (CSF) 分流系統手術治療腦積水是對兒童和成人患者進行的常見神經外科手術。分流器可以將多餘的腦脊髓液 (CSF) 引流至身體的其他部位。
該報告深入探討了全球腦積水分流器市場,包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。
Hydrocephalus Shunts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Hydrocephalus Shunts market for the year 2020 and beyond. Surgical treatment of hydrocephalus with a Cerebrospinl Fluid (CSF) Shunting system is a common neurosurgery procedure performed on both paediatric and adult patients. Shunts allow excess Cerebrospinal Fluid (CSF) to drain to another area of the body. In this segment, shunt valves and shunt catheters are considered.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Hydrocephalus Shunts and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Medtronic Plc, Integra LifeSciences Holdings Corp, Sophysa SA, Aesculap Inc, Spiegelberg GmbH & Co KG, Natus Medical Inc, Hpbio, G. Surgiwear Ltd and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable